Financials

  • Market Capitalization 6.38 B
  • Employee 258
  • Founded 2014
  • CEO N/A
  • Website www.cogentbio.com
  • Headquarter Delaware, United States
  • FIGI BBG007DHZQR7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-16.44
Price to sales ratio
-637.59

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1149
SRRK
Scholar Rock Holding Corporation - Common Stock
54.74 USD-3.47%-1.60%+22.43%+82.35%6.56 B USD
1165
XENE
Xenon Pharmaceuticals Inc. - Common Shares
67.00 USD-2.79%+11.09%+28.80%+64.26%6.48 B USD
1189
LGND
Ligand Pharmaceuticals Incorporated - Common Stock
311.79 USD-1.41%-2.31%+22.28%+66.63%6.25 B USD
1191
LQDA
Liquidia Corporation - Common Stock
70.78 USD-9.17%-11.84%+0.55%+213.19%6.29 B USD

Frequently asked questions about Cogent Biosciences, Inc. - Common Stock

What is the Cogent Biosciences, Inc. - Common Stock stock price today?

The current price of Cogent Biosciences, Inc. - Common Stock (COGT) is 37.35. Over the past 24 hours, the stock has changed by -3.91%. Follow the COGT chart for real-time price dynamics.

What is the stock ticker of Cogent Biosciences, Inc. - Common Stock?

Cogent Biosciences, Inc. - Common Stock trades under the ticker COGT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Cogent Biosciences, Inc. - Common Stock stock going up?

COGT has changed by -5.13% over the last week, +14.71% over the last month, and +138.35% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Cogent Biosciences, Inc. - Common Stock net income for the last quarter?

Cogent Biosciences, Inc. - Common Stock reported net income of -97.35 M for the last quarter. The previous quarter showed -102.49 M, which means net income changed by +5.02%.

How many employees does Cogent Biosciences, Inc. - Common Stock have?

As of the latest available data, Cogent Biosciences, Inc. - Common Stock has 258 employees. Workforce size can provide additional context about the company's scale and operations.

What is Cogent Biosciences, Inc. - Common Stock EBITDA?

Cogent Biosciences, Inc. - Common Stock EBITDA is -104.64 M, and its EBITDA margin is 77.51 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Cogent Biosciences, Inc. - Common Stock stock?

You can buy Cogent Biosciences, Inc. - Common Stock (COGT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Cogent Biosciences, Inc. - Common Stock stock?

Investing in Cogent Biosciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COGT chart and related analysis on metatrader.com as part of your research.

News